日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Cost Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada: An Analysis Using Real-World Evidence from the EVOLVE Study

在加拿大，维多珠单抗作为溃疡性结肠炎和克罗恩病一线生物制剂的序贯治疗的成本效益分析：基于EVOLVE研究真实世界证据的分析

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-024-00523-5
Fischer, Aren; Mac, Stephen; Freiman, Erica Stivelman; Marshall, John K; Rand, Kim; Ramos-Goñi, Juan M
结肠炎
克罗恩病
肠炎
发表日期：2025
文献求助 收藏

Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes

血液透析期间脉压降低与6个月预后改善相关。

期刊:Kidney International
影响因子:12.6
doi:10.1038/ki.2009.340
Inrig, Jula K; Patel, Uptal D; Toto, Robert D; Reddan, Donal N; Himmelfarb, Jonathan; Lindsay, Robert M; Stivelman, John; Winchester, James F; Szczech, Lynda A
发表日期：2009
文献求助 收藏

Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients

透析中血压变化与终末期肾病患者住院率和死亡率的关系

期刊:Kidney International
影响因子:12.6
doi:10.1038/sj.ki.5002077
Inrig, J K; Oddone, E Z; Hasselblad, V; Gillespie, Barbara; Patel, U D; Reddan, D; Toto, R; Himmelfarb, J; Winchester, J F; Stivelman, J; Lindsay, R M; Szczech, L A
发表日期：2007
文献求助 收藏

Relationship between interdialytic weight gain and blood pressure among prevalent hemodialysis patients

透析间期体重增加与血液透析患者血压的关系

期刊:American Journal of Kidney Diseases
影响因子:8.2
doi:10.1053/j.ajkd.2007.04.020
Inrig, Jula K; Patel, Uptal D; Gillespie, Barbara S; Hasselblad, Vic; Himmelfarb, Jonathan; Reddan, Donal; Lindsay, Robert M; Winchester, James F; Stivelman, John; Toto, Robert; Szczech, Lynda A
发表日期：2007
文献求助 收藏